CN108359703A - The preparation method and application of Yi Zhong angler fracture tumour dodecapeptides - Google Patents
The preparation method and application of Yi Zhong angler fracture tumour dodecapeptides Download PDFInfo
- Publication number
- CN108359703A CN108359703A CN201810040906.4A CN201810040906A CN108359703A CN 108359703 A CN108359703 A CN 108359703A CN 201810040906 A CN201810040906 A CN 201810040906A CN 108359703 A CN108359703 A CN 108359703A
- Authority
- CN
- China
- Prior art keywords
- angler
- peak
- tumour
- fracture
- ultrafiltration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000276420 Lophius piscatorius Species 0.000 title claims abstract description 56
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 31
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 24
- 229940036811 bone meal Drugs 0.000 claims abstract description 16
- 239000002374 bone meal Substances 0.000 claims abstract description 16
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 9
- 238000012545 processing Methods 0.000 claims abstract description 7
- 239000012528 membrane Substances 0.000 claims abstract description 6
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 101000693530 Staphylococcus aureus Staphylokinase Proteins 0.000 claims abstract description 5
- 238000005360 mashing Methods 0.000 claims abstract description 4
- 239000002245 particle Substances 0.000 claims abstract description 4
- 210000001519 tissue Anatomy 0.000 claims abstract description 4
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 21
- 238000001514 detection method Methods 0.000 claims description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 206010060862 Prostate cancer Diseases 0.000 claims description 10
- 239000003480 eluent Substances 0.000 claims description 10
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- 238000004007 reversed phase HPLC Methods 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 230000000259 anti-tumor effect Effects 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 6
- 238000002474 experimental method Methods 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 230000001093 anti-cancer Effects 0.000 claims description 5
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 5
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 229920005654 Sephadex Polymers 0.000 claims description 4
- 239000012507 Sephadex™ Substances 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 239000012149 elution buffer Substances 0.000 claims description 4
- 239000006167 equilibration buffer Substances 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 239000007791 liquid phase Substances 0.000 claims description 4
- 238000002203 pretreatment Methods 0.000 claims description 4
- 239000007853 buffer solution Substances 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 235000013376 functional food Nutrition 0.000 claims description 2
- 230000005764 inhibitory process Effects 0.000 claims description 2
- 230000009246 food effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 3
- 239000000523 sample Substances 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 241000251468 Actinopterygii Species 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241000985719 Antennariidae Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- 241001417045 Lophius litulon Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- -1 is centrifuged Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The preparation method and application of Yi Zhong angler fracture tumour dodecapeptides, its Xuan Yong angler bone as raw material, the method includes：a）Particle：Angler bone carried out with high-speed tissue mashing machine to smash processing to pieces, powdery and microparticulate angler bone meal is made；b）Enzymolysis：Neutral proteinase Dui angler bone meal is selected to digest, Cheng anglers bone meal enzymolysis liquid processed；c）Ultrafiltration：Ultrafiltration system is added in angler bone meal enzymolysis liquid, ultrafiltration is carried out with the ultrafiltration membrane of 10KD, 5KD, 3KD, is collected>10KD, 10 5KD, 5 3KD and<The enzymolysis liquid of 3KD molecular weight, is freeze-dried.
Description
Technical field
Of the present invention is the preparation method and application of Yi Zhong angler fracture tumour dodecapeptides, and especially one kind is to preceding
The preparation method and application of the inhibited anglers fracture tumour dodecapeptide of row adenocarcinoma cell.
Background technology
Traditional treatment means include mainly prostate cancer radical excision, hormone therapy, chemotherapy, radiotherapy etc., but
Cancer is difficult to eradicate after treatment, and recurrence rate is high.Therefore, efficient one kind, low toxicity are found from ocean and with relatively strong specific
New type antineoplastic medicine have important research significance and clinical meaning.
During processing of aquatic products, a large amount of leftover bits and pieces will produce（Including fish head, fish-skin, fin, fish tail, fish-bone and
It remains the flesh of fish）, quality accounts for about the 30%~55% of raw material fish, and the content of different parts collagen is differed from 20%~50%.
Angler（Lophius litulon）Belong to cold warm nature demersal fishes, volt seabed of often dwelling is distributed in North Western Pacific, China's production
In northern East China Sea, the Huanghai Sea and the Bohai Sea.Wo Guo anglers demand for exports in recent years is vigorous, and , anglers are significantly increased in yield and price
Exporting oneself becomes the emerging fishery in China.Ran and in the processing of , anglers, a large amount of fish-skins are discarded as leftover bits and pieces, this
Environment is not only polluted, the waste of resource is also resulted in.Currently, for the economic value added of Ti Gao angler skins, has scholar
Begin one's study extraction dermatan sulfate, chondroitin sulfate, collagen etc. in Cong angler processing byproducts.
Active peptide is the compound being connected with peptide bond by two or more amino acid, and important physiology is played in human body
Effect plays physiological function, such as：Adjust internal moisture, electrolyte balance；Promote wound healing；Repair cell improves cell
Metabolism, can play protective effect on cancer risk etc..Active peptide is generally obtained by digesting bioactive materials, and research finds that food proteins pass through
Protease hydrolyzed mode can obtain active peptides vdiverse in function.
Invention content
It is an object of the invention to overcome the shortcomings of the prior art, and one kind is provided and passes through the white Mei Dui angler fishes of Dan
Bone is digested to obtain a kind of polypeptide yield Gao angler fractures inhibited to prostate gland cancer cell, extraction
The preparation method and application of tumour dodecapeptide.
The purpose of the present invention is by following technical solution to complete, the preparations of Yi Zhong angler fracture tumour dodecapeptides
Method, its Xuan Yong angler bone as raw material, and the preparation method includes the following steps：
a）Particle：Angler bone carried out with high-speed tissue mashing machine to smash processing to pieces, powdery and microparticulate anglers is made
Bone meal；
b）Enzymolysis：Neutral proteinase Dui angler bone meal is selected to digest, Cheng anglers bone meal enzymolysis liquid processed；
c）Ultrafiltration：Ultrafiltration system is added in angler bone meal enzymolysis liquid, ultrafiltration is carried out with the ultrafiltration membrane of 10KD, 5KD, 3KD, is collected
>10KD, 10-5KD, 5-3KD and<The enzymolysis liquid of 3KD molecular weight, is freeze-dried,
d）Angler enzymolysis liquid crosses G-25 eluents and obtains 5 peaks, is screened through anticancer experiment in vitro, and peak 2 and peak 3 have highest
Antitumor activity, collect peak 2 and peak 3, freeze-drying further isolates and purifies and with efficient liquid phase purity detecting；
e）By reversed-phase high performance liquid chromatography (RT-HPLC) purifying and amino acid sequence detection：Peak 3 is detected with HPLC and is found, should
Molecule section only has 1 eluting peak, and carries out amino acid sequence detection, and amino acid sequence is Met-Trp- Ile-Phe-His-
Asp-Ser-Asp- Lys-Asn- Cys- Arg；Cheng anglers fracture tumour dodecapeptide product processed.
As preferred：The step b）Enzymatic hydrolysis condition is：pH:7.0-7.5, temperature：40-45 DEG C, solid-liquid ratio：1:1, when
Between：5-7h, enzyme concentration:1200-1500 u/g；
The step d）In, the G-25 gels separation is：By step c）The enzymolysis liquid of acquisition is dissolved with distilled water, from
The heart takes supernatant, crosses 0.45 μm of miillpore filter, and enzymolysis liquor 1.5ml is taken to cross Sephadex G-25 columns (90cm × 115cm
(ID)) it is, eluent with distilled water, balance and elution；Often pipe collects 3ml, is detected at 280 nm of λ, collects each peak elution
Liquid；
The step e）In, the reversed-phase high performance liquid chromatography (RT- HPLC) is：Purified with RT-HPLC, chromatography
Condition:1) sample pre-treatments:Sample is centrifuged with the water dissolution of 0.06%TFA to 0.6ml（12000-14000 RPM, centrifugation
10 minutes）Take supernatant；2) system: Agilent 1260 HPLC；3) pillar:ZorbaxSB-C18 4.6X250 5um；4) into
Sample volume:80-100ul；5) buffer solution, equilibration buffer:0.06%TFA elution buffers:The acetonitrile of 0.05%TFA；6) terraced
Degree:0% -0 % B are eluted 4 minutes, and 0% -8% B is eluted 25 minutes, and 8%-100%B is eluted 1 minute, and 100% -100%B elutes 5 points
Clock；7) flow velocity:1.0 ml/min；8）Detection:280nm/214nm.
A kind of application of the Suo Shu anglers fracture tumour dodecapeptide on, Suo Shu angler fracture tumour decapeptides are as work(
Energy food is used for the additional functionality food of patients with prostate cancer, apparent to the inhibiting effect of prostate cancer.
The present invention digests angler fish-bone powder raw material by the white enzyme of egg a kind of to prostate gland cancer cell to obtain
Inhibited ten peptide product of angler fracture tumour has the characteristics that the polypeptide yield of extraction is high.
Description of the drawings
Fig. 1 is anticancer experiment in vitro screening figure of this invention Suo Shu anglers enzymolysis liquids after 25 eluents of G-.
Fig. 2 is that the molecule section obtained with HPLC detections of the present invention elutes peak value figure.
Fig. 3 is dodecapeptide of the present invention to the active influence diagram of 3 cell proliferations of PC-.
Specific implementation mode
Below in conjunction with specific embodiment and testing inspection figure etc., the present invention will be described in detail：Of the present invention one
The preparation method of Zhong angler fracture tumour dodecapeptides, its Xuan Yong angler bone as raw material, and the preparation method includes such as
Lower step：
a）Particle：Angler bone carried out with high-speed tissue mashing machine to smash processing to pieces, powdery and microparticulate anglers is made
Bone meal；
b）Enzymolysis：Neutral proteinase Dui angler bone meal is selected to digest, Cheng anglers bone meal enzymolysis liquid processed；
c）Ultrafiltration：Ultrafiltration system is added in angler bone meal enzymolysis liquid, ultrafiltration is carried out with the ultrafiltration membrane of 10KD, 5KD, 3KD, is collected
>10KD, 10-5KD, 5-3KD and<The enzymolysis liquid of 3KD molecular weight, is freeze-dried,
d）Angler enzymolysis liquid crosses G-25 eluents and obtains 5 peaks, is screened through anticancer experiment in vitro, and peak 2 and peak 3 have highest
Antitumor activity, collect peak 2 and peak 3, freeze-drying further isolates and purifies and with efficient liquid phase purity detecting；
e）By reversed-phase high performance liquid chromatography (RT-HPLC) purifying and amino acid sequence detection：Peak 3 is detected with HPLC and is found, should
Molecule section only has 1 eluting peak, and carries out amino acid sequence detection, and amino acid sequence is Met-Trp- Ile-Phe-His-
Asp-Ser-Asp- Lys-Asn- Cys- Arg；Cheng anglers fracture tumour dodecapeptide product processed.
Step b of the present invention）Enzymatic hydrolysis condition is：pH:7.0-7.5, temperature：40-45 DEG C, solid-liquid ratio：1:1, the time：
5-7h, enzyme concentration:1200-1500 u/g；
The step d）In, the G-25 gels separation is：By step c）The enzymolysis liquid of acquisition is dissolved with distilled water, from
The heart takes supernatant, crosses 0.45 μm of miillpore filter, and enzymolysis liquor 1.5ml is taken to cross Sephadex G-25 columns (90cm × 115cm
(ID)) it is, eluent with distilled water, balance and elution；Often pipe collects 3ml, is detected at 280 nm of λ, collects each peak elution
Liquid；
The step e）In, the reversed-phase high performance liquid chromatography (RT- HPLC) is：Purified with RT-HPLC, chromatography
Condition:1) sample pre-treatments:Sample is centrifuged with the water dissolution of 0.06%TFA to 0.6ml（12000-14000 RPM, centrifugation
10 minutes）Take supernatant；2) system: Agilent 1260 HPLC；3) pillar:ZorbaxSB-C18 4.6X250 5um；4) into
Sample volume:80-100ul；5) buffer solution, equilibration buffer:0.06%TFA elution buffers:The acetonitrile of 0.05%TFA；6) terraced
Degree:0% -0 % B are eluted 4 minutes, and 0% -8% B is eluted 25 minutes, and 8%-100%B is eluted 1 minute, and 100% -100%B elutes 5 points
Clock；7) flow velocity:1.0 ml/min；8）Detection:280nm/214nm.
A kind of application of the Suo Shu anglers fracture tumour dodecapeptide on, Suo Shu angler fracture tumour dodecapeptide conducts
Functional food is used for the additional functionality food of patients with prostate cancer, apparent to the inhibiting effect of prostate cancer.
Experimental method：
One, the optimization of enzymatic hydrolysis condition：
1, neutral proteinase is selected, is digested with its optimum enzymolysis condition.Its enzymatic hydrolysis condition is：pH:7.0-7.5, temperature：
40-45 DEG C, solid-liquid ratio：1:1, the time：5-7h, enzyme concentration:1200-1500 u/g.
2, cell culture：Choose Human Prostate Cancer Cells PC-3 hormone independent cells（Original is thin purchased from Chinese Academy of Sciences Shanghai
Born of the same parents library, is preserved by this laboratory passage）.PC-3 uses the F12 cultures containing 10% fetal calf serum to be based on 37 DEG C, in 5% CO2 incubators
It cultivates to exponential phase.
3, ultrafiltration：Ultrafiltration system is added in sample, ultrafiltration is carried out with the ultrafiltration membrane of 10KD, 5KD, 3KD, is collected>10KD、
10-5KD, 5-3KD and<The enzymolysis liquid of 3KD molecular weight, is freeze-dried.And carry out active anticancer screening.Strongest point of activity
Son amount further purifies.
4, G-25 gels detach：Sample is dissolved with distilled water, is centrifuged, supernatant is taken, crosses 0.45 μm of miillpore filter,
It takes sample solution 1.5ml to cross Sephadex G-25 columns (90cm × 115cm (ID)), is eluent with distilled water, balances and wash
It is de-.Often pipe collects 3ml, is detected at λ 280nm, collects each peak eluent.
5, reversed-phase high performance liquid chromatography (RT-HPLC)：RT-HPLC is purified.Chromatographic condition:1) sample pre-treatments:It will
Sample, to 0.6ml, is centrifuged with the water dissolution of 0.06%TFA（12000-14000 RPM are centrifuged 10 minutes）Take supernatant；2) system:
Agilent1260 HPLC；3) pillar:Zorbax SB-C18 4.6 X 250 5um；4) sampling volume:80-100ul；5) delay
Fliud flushing equilibration buffer:0.06%TFA elution buffers:The acetonitrile of 0.05%TFA；6) gradient:0% -0% B is eluted 4 minutes,
0% -8% B is eluted 25 minutes, and 8%-100%B is eluted 1 minute, and 100%-100%B is eluted 5 minutes；7) flow velocity:1.0 ml/min；8）
Detection:280nm/214nm
Two experimental results：
1, ultrafiltration and antitumor activity screening：Ultrafiltration system is added in enzymolysis sample, is carried out with the ultrafiltration membrane of 10KD, 5KD, 3KD
Ultrafiltration is collected>10KD, 8-5KD, 5-3KD and<The enzymolysis liquid of 3KD molecular weight, is freeze-dried.PC-3 is carried out with MTT methods
Cell proliferation inhibition rate is tested, and is found<The enzymolysis liquid energy of 3KD molecular weight effectively inhibits PC-3 to be proliferated.Therefore it will<3KD molecular weight
Enzymolysis liquid carries out isolating and purifying for next step.
2, G-25 isolates and purifies result：, angler enzymolysis liquids as shown in Figure 1 cross G-25 eluents and obtain 5 peaks, through external
Anti-tumor experiment screens, and peak 2 and peak 3 have highest antitumor activity, collects peak 2 and peak 3, and freeze-drying further divides
From purifying and with efficient liquid phase purity detecting.
3, reversed-phase high performance liquid chromatography (RT-HPLC) purifying and amino acid sequence detection：Shown in Fig. 2, peak 3 is detected with HPLC
It was found that the molecule section only has 1 eluting peak, and amino acid sequence detection is carried out, amino acid sequence is Met-Trp- Ile-
Phe-His-Asp-Ser-Asp- Lys-Asn- Cys- Arg。
4, influence of the dodecapeptide to PC-3 cell-proliferation activities：Using F12 as control group, compare various concentration dodecapeptide pair
The influence of PC-3 cell Proliferations.Each concentration, each time point PC-3 cell-proliferation activities as shown in Figure 3, indicate in figure：Dodecapeptide energy
Effectively inhibit PC-3 proliferation, and is in concentration and time dependence.
Claims (3)
1. the preparation method of Yi Zhong angler fracture tumour dodecapeptides, its Xuan Yongs angler bone as raw material, it is characterised in that institute
The preparation method stated includes the following steps：
a）Particle：Angler bone carried out with high-speed tissue mashing machine to smash processing to pieces, powdery and microparticulate anglers is made
Bone meal；
b）Enzymolysis：Neutral proteinase Dui angler bone meal is selected to digest, Cheng anglers bone meal enzymolysis liquid processed；
c）Ultrafiltration：Ultrafiltration system is added in angler bone meal enzymolysis liquid, ultrafiltration is carried out with the ultrafiltration membrane of 10KD, 5KD, 3KD, is collected
>10KD, 10-5KD, 5-3KD and<The enzymolysis liquid of 3KD molecular weight, is freeze-dried,
d）Angler enzymolysis liquid crosses G-25 eluents and obtains 5 peaks, is screened through anticancer experiment in vitro, and peak 2 and peak 3 have highest
Antitumor activity, collect peak 2 and peak 3, freeze-drying further isolates and purifies and with efficient liquid phase purity detecting；
e）By reversed-phase high performance liquid chromatography (RT-HPLC) purifying and amino acid sequence detection：Peak 3 is detected with HPLC and is found, should
Molecule section only has 1 eluting peak, and carries out amino acid sequence detection, and amino acid sequence is Met-Trp- Ile-Phe-His-
Asp-Ser-Asp- Lys-Asn- Cys- Arg；Cheng anglers fracture tumour dodecapeptide product processed.
2. according to the preparation method of claim 1 Suo Shu angler fracture tumour dodecapeptides, it is characterised in that：
The step b）Enzymatic hydrolysis condition is：pH:7.0-7.5, temperature：40-45 DEG C, solid-liquid ratio：1:1, the time：5-7h, it is enzyme
Amount:1200-1500 u/g；
The step d）In, the G-25 gels separation is：By step c）The enzymolysis liquid of acquisition is dissolved with distilled water, from
The heart takes supernatant, crosses 0.45 μm of miillpore filter, and enzymolysis liquor 1.5ml is taken to cross Sephadex G-25 columns (90cm × 115cm
(ID)) it is, eluent with distilled water, balance and elution；Often pipe collects 3ml, is detected at 280 nm of λ, collects each peak elution
Liquid；
The step e）In, the reversed-phase high performance liquid chromatography (RT- HPLC) is：Purified with RT-HPLC, chromatography
Condition:1) sample pre-treatments:Sample is centrifuged with the water dissolution of 0.06%TFA to 0.6ml（12000-14000 RPM, centrifugation
10 minutes）Take supernatant；2) system: Agilent 1260 HPLC；3) pillar:ZorbaxSB-C18 4.6X250 5um；4) into
Sample volume:80-100ul；5) buffer solution, equilibration buffer:0.06%TFA elution buffers:The acetonitrile of 0.05%TFA；6) terraced
Degree:0% -0 % B are eluted 4 minutes, and 0% -8% B is eluted 25 minutes, and 8%-100%B is eluted 1 minute, and 100% -100%B elutes 5 points
Clock；7) flow velocity:1.0 ml/min；8）Detection:280nm/214nm.
3. a kind of application such as claims 1 or 2 Suo Shu angler fracture tumour dodecapeptides, it is characterised in that Suo Shu anglers
Fracture tumour dodecapeptide is used for the additional functionality food of patients with prostate cancer, the inhibition to prostate cancer as functional food
Effect is apparent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810040906.4A CN108359703A (en) | 2018-01-16 | 2018-01-16 | The preparation method and application of Yi Zhong angler fracture tumour dodecapeptides |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810040906.4A CN108359703A (en) | 2018-01-16 | 2018-01-16 | The preparation method and application of Yi Zhong angler fracture tumour dodecapeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108359703A true CN108359703A (en) | 2018-08-03 |
Family
ID=63006346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810040906.4A Pending CN108359703A (en) | 2018-01-16 | 2018-01-16 | The preparation method and application of Yi Zhong angler fracture tumour dodecapeptides |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108359703A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110343072A (en) * | 2019-07-12 | 2019-10-18 | 浙江海洋大学 | A method of carnosine is extracted from stripped tuna head |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102690370A (en) * | 2011-12-20 | 2012-09-26 | 浙江省海洋开发研究院 | Comprehensive utilization technique of marine fish bones |
| CN103805662A (en) * | 2012-11-15 | 2014-05-21 | 浙江海洋学院 | Preparation method and application of sinonovacula constricta enzymolysis polypeptide |
| CN104304647A (en) * | 2014-09-12 | 2015-01-28 | 浙江海洋学院 | Monkfish leftover classification using method |
| CN104774896A (en) * | 2015-04-15 | 2015-07-15 | 浙江海洋学院 | Preparation method for iron-chelated collagen peptide of hairtail fish-bones |
-
2018
- 2018-01-16 CN CN201810040906.4A patent/CN108359703A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102690370A (en) * | 2011-12-20 | 2012-09-26 | 浙江省海洋开发研究院 | Comprehensive utilization technique of marine fish bones |
| CN103805662A (en) * | 2012-11-15 | 2014-05-21 | 浙江海洋学院 | Preparation method and application of sinonovacula constricta enzymolysis polypeptide |
| CN104304647A (en) * | 2014-09-12 | 2015-01-28 | 浙江海洋学院 | Monkfish leftover classification using method |
| CN104774896A (en) * | 2015-04-15 | 2015-07-15 | 浙江海洋学院 | Preparation method for iron-chelated collagen peptide of hairtail fish-bones |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110343072A (en) * | 2019-07-12 | 2019-10-18 | 浙江海洋大学 | A method of carnosine is extracted from stripped tuna head |
| CN110343072B (en) * | 2019-07-12 | 2023-01-31 | 浙江海洋大学 | Method for extracting carnosine from skipjack heads |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102558296B (en) | Mytilus edulis enzymolysis polypeptide and preparation method and application thereof | |
| CN103805662A (en) | Preparation method and application of sinonovacula constricta enzymolysis polypeptide | |
| CN106632605A (en) | Liver injury and repair type active peptide prepared from tuna offal | |
| CN105330723B (en) | A kind of biologically active peptide | |
| CN104593462B (en) | A kind of preparation method of blue clam albumen source ACE inhibitor peptides | |
| CN105175500A (en) | Active polypeptide prepared by high performance liquid chromatography and application thereof | |
| CN108359703A (en) | The preparation method and application of Yi Zhong angler fracture tumour dodecapeptides | |
| CN107177650B (en) | Preparation method of antioxidant enzymolysis oligopeptide from peripherical glands of northern pacific squid | |
| CN106755230B (en) | Preparation method of perinereis aibuhitensis anti-lung cancer polypeptide | |
| CN108396047A (en) | A kind of preparation method of small public fish immunomodulatory peptides | |
| CN108359702A (en) | The preparation method and application of Yi Zhong angler fracture tumour decapeptides | |
| CN104877007A (en) | Yak milk lactalbumin-source ACE inhibitory peptides and preparation method thereof | |
| CN107173815B (en) | Application of antioxidant enzymolysis oligopeptide from peripherical glands of northern pacific squid | |
| CN103571904B (en) | The preparation method of Yi Zhong Channel-catfish collagen of fish skin ace inhibitory peptide | |
| CN112877390B (en) | Preparation method of functional alcohol-soluble sturgeon cartilage preparation | |
| CN115124591A (en) | Spirulina platensis phycocyanin angiotensin converting enzyme inhibitory peptide and preparation method and application thereof | |
| CN107176973B (en) | Antioxidative enzymolysis oligopeptide from peri-pacific squid oothecal gland | |
| CN105315344B (en) | Solen active hexapeptide and preparation method and application thereof | |
| CN105085619B (en) | Sinonovacula constricta active decapeptide and preparation method and application thereof | |
| CN105085618B (en) | Sinonovacula constricta active octapeptide and preparation method and application thereof | |
| CN105315343B (en) | Solen active octapeptide and preparation method and application thereof | |
| CN106518997B (en) | A kind of clarias leather antibacterial peptide and extracting method | |
| CN111763243A (en) | Gorgon fish immune active peptide and preparation method and application thereof | |
| CN105315336B (en) | Solen active tripeptide and preparation method and application thereof | |
| CN105315337A (en) | Active tetrapeptide of Sinonovacula constricta and preparation method therefor and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180803 |
|
| RJ01 | Rejection of invention patent application after publication |